New drug combo shows promise in advanced lung cancer trial
Disease control
Completed
This early-phase study tested a combination of two drugs—nivolumab (a standard immunotherapy) and plinabulin (an experimental drug that targets tumor blood vessels and kills cancer cells)—in 18 adults with advanced non-small cell lung cancer that had worsened after chemotherapy. …
Phase: PHASE1 • Sponsor: Lyudmila Bazhenova, M.D. • Aim: Disease control
Last updated May 26, 2026 11:09 UTC